We are live on
!
Find out more
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
CTIC
Delisted
CTIC was delisted on the 23rd of June, 2023.
40 hedge funds and large institutions have $39.2M invested in CTI BioPharma Corp. (DE) Common Stock in 2019 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 8 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
87% more capital invested
Capital invested by funds: $21M → $39.2M (+$18.2M)
13% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 8
7% less funds holding
Funds holding: 43 → 40 (-3)
33% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 9
Holders
40
Holders Change
-3
Holders Change %
-6.98%
% of All Funds
0.79%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
6
Increased
9
Reduced
8
Closed
9
Calls
$189K
Puts
–
Net Calls
+$189K
Net Calls Change
+$155K
Top Buyers
Top Sellers
| 1 |
Millennium Management
New York
|
-$197K |
| 2 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$134K |
| 3 |
JP Morgan Chase
New York
|
-$123K |
| 4 |
Squarepoint
New York
|
-$75K |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$67K |
